Kenji Arakawa Selected Research

Kenji Arakawa Research Topics

Disease

9	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2005
5	Body Weight (Weight, Body) 01/2020 - 01/2012
3	Hyperglycemia 01/2015 - 04/2005
2	Albuminuria 01/2022 - 02/2014
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2021
2	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 11/2014
2	Inflammation (Inflammations) 10/2018 - 01/2017
2	Obesity 01/2017 - 01/2012
1	Hypoxia (Hypoxemia) 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Proteinuria 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Nephritis 01/2021
1	Allergic Rhinitis 01/2017
1	Dehydration (Water Stress) 01/2017
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Immediate Hypersensitivity 01/2017
1	Leukemia 01/2017
1	Glucose Intolerance 04/2015
1	Hyperinsulinism (Hyperinsulinemia) 01/2015
1	Insulin Resistance 01/2015
1	Weight Gain 01/2015
1	Hypoalbuminemia 02/2014
1	Necrosis 01/2012
1	Hereditary Spastic Paraplegia 12/2011
1	Diabetes Mellitus 01/2006
1	Diabetic Neuropathies (Diabetic Neuropathy) 04/2005
1	Cardiomegaly (Heart Hypertrophy) 01/2004
1	Myotonic Dystrophy (Dystrophia Myotonica) 03/2003

Drug/Important Bio-Agent (IBA)

10	CanagliflozinIBA 01/2022 - 01/2012
10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2005
8	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2012
3	Sodium-Glucose Transport ProteinsIBA 01/2022 - 04/2015
3	SodiumIBA 01/2022 - 01/2012
2	AlbuminsIBA 01/2021 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2018
2	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 01/2020 - 04/2015
2	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2016 - 04/2015
2	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2015 - 04/2015
2	Insulin (Novolin)FDA Link 01/2015 - 11/2014
2	SymportersIBA 01/2015 - 01/2012
2	Blood Glucose (Blood Sugar)IBA 02/2014 - 01/2006
2	T 1095IBA 01/2006 - 04/2005
1	CreatinineIBA 01/2022
1	CalcineurinIBA 01/2021
1	NPHS2 proteinIBA 01/2021
1	Puromycin AminonucleosideIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	DesminIBA 01/2021
1	nephrinIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	glimepiride (Amarel)FDA LinkGeneric 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	8-Hydroxy-2'-DeoxyguanosineIBA 10/2018
1	flavanoneIBA 01/2017
1	Immunoglobulin E (IgE)IBA 01/2017
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2017
1	PolyphenolsIBA 01/2017
1	PhytochemicalsIBA 01/2017
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 04/2015
1	Pioglitazone (Actos)FDA Link 01/2015
1	imidaprilIBA 02/2014
1	borrelidinIBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 12/2011
1	Streptozocin (Streptozotocin)FDA Link 01/2004
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2004
1	ThiazolidinedionesIBA 01/2004
1	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2004
1	Protein Kinases (Protein Kinase)IBA 03/2003

Therapy/Procedure

7	Glycemic Control 01/2020 - 01/2012
2	Therapeutics 01/2020 - 01/2015
2	Oral Administration 01/2017 - 02/2014
1	Exercise Therapy (Therapy, Exercise) 01/2020